Published 2000
| Version v1.0.0
Journal Article
Open
High-Dose IV Immunoglobulin in Juvenile Myasthenia
Creators
Abstract
Ten children (median age, 13 years; range, 3-18 yrs) with juvenile myasthenia gravis were treated with high-dose intravenous immunoglobulin (2 gm/kg body wt) and prospectively evaluated for 5 years at the Department of Neurology, Wayne State University, Childrens Hospital of Michigan, Detroit, MI.Files
PNB-14-26-b.pdf
Files
(1.5 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d832ec3c9d2958567f23f13e1ccb6295
|
1.5 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-14-26-b
Dates
- Created
-
2000When the item was originally created.